Published in Arch Neurol on November 01, 2002
Systematic Multi-domain Alzheimer's Risk Reduction Trial (SMARRT) | NCT03683394
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 24.02
The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics (2011) 9.20
Electronic medical records for genetic research: results of the eMERGE consortium. Sci Transl Med (2011) 5.82
Glucose levels and risk of dementia. N Engl J Med (2013) 4.95
Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. JAMA Intern Med (2015) 4.57
Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA (2010) 4.36
Epigenetic mechanisms in Alzheimer's disease. Neurobiol Aging (2011) 3.83
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol (2012) 3.77
Association of the built environment with physical activity and obesity in older persons. Am J Public Health (2007) 3.60
Genomic research and wide data sharing: views of prospective participants. Genet Med (2010) 3.45
Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genet Med (2012) 3.29
Glad you asked: participants' opinions of re-consent for dbGap data submission. J Empir Res Hum Res Ethics (2010) 3.29
Research ethics. Research practice and participant preferences: the growing gulf. Science (2011) 3.27
A network diffusion model of disease progression in dementia. Neuron (2012) 3.03
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci (2009) 2.86
Association of incident dementia with hospitalizations. JAMA (2012) 2.74
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58
Age-varying association between statin use and incident Alzheimer's disease. J Am Geriatr Soc (2010) 2.34
Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology (2009) 2.32
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology (2012) 2.19
Adjustment for selection bias in observational studies with application to the analysis of autopsy data. Neuroepidemiology (2009) 2.11
Incidence of dementia among participants and nonparticipants in a longitudinal study of cognitive aging. Am J Epidemiol (2014) 2.09
Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study. Alzheimer Dis Assoc Disord (2012) 2.02
Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline. J Clin Epidemiol (2008) 1.93
Ethical and practical challenges of sharing data from genome-wide association studies: the eMERGE Consortium experience. Genome Res (2011) 1.91
Epidemiology of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.78
Ecology of the aging human brain. Arch Neurol (2011) 1.78
Blood pressure and brain injury in older adults: findings from a community-based autopsy study. J Am Geriatr Soc (2009) 1.76
Free radical damage to cerebral cortex in Alzheimer's disease, microvascular brain injury, and smoking. Ann Neurol (2009) 1.71
Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. CMAJ (2008) 1.70
Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol (2010) 1.68
Incidence of dementia and cognitive impairment, not dementia in the United States. Ann Neurol (2011) 1.63
Alzheimer's disease is not "brain aging": neuropathological, genetic, and epidemiological human studies. Acta Neuropathol (2011) 1.62
Clinical epidemiology of Alzheimer's disease: assessing sex and gender differences. Clin Epidemiol (2014) 1.56
Olfaction and the 5-year incidence of cognitive impairment in an epidemiological study of older adults. J Am Geriatr Soc (2008) 1.46
Differences in Alzheimer disease clinical trial outcomes based on age of the participants. Neurology (2015) 1.45
Relationship between education and dementia: an updated systematic review. Alzheimer Dis Assoc Disord (2011) 1.42
Robust and conventional neuropsychological norms: diagnosis and prediction of age-related cognitive decline. Neuropsychology (2008) 1.41
APOE ε4 increases risk for dementia in pure synucleinopathies. JAMA Neurol (2013) 1.41
Addressing the challenges to successful recruitment and retention in Alzheimer's disease clinical trials. Alzheimers Res Ther (2010) 1.39
Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play. Radiology (2012) 1.34
The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy. Br J Pharmacol (2005) 1.32
Pre-clinical detection of Alzheimer's disease using FDG-PET, with or without amyloid imaging. J Alzheimers Dis (2010) 1.28
Genetic aspects of Alzheimer disease. Genet Med (2008) 1.26
Risk and protective effects of the APOE gene towards Alzheimer's disease in the Kungsholmen project: variation by age and sex. J Neurol Neurosurg Psychiatry (2004) 1.25
Central auditory dysfunction as a harbinger of Alzheimer dementia. Arch Otolaryngol Head Neck Surg (2011) 1.24
Temporal relationship between depression and dementia: findings from a large community-based 15-year follow-up study. Arch Gen Psychiatry (2011) 1.23
Risk for late-life re-injury, dementia and death among individuals with traumatic brain injury: a population-based study. J Neurol Neurosurg Psychiatry (2012) 1.22
Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? Br J Clin Pharmacol (2011) 1.22
Atrial fibrillation and risk of dementia: a prospective cohort study. J Am Geriatr Soc (2011) 1.18
Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes. Hum Genomics (2010) 1.12
Incorporating ethnicity into genetic risk assessment for Alzheimer disease: the REVEAL study experience. Genet Med (2008) 1.08
Risk factors for dementia after critical illness in elderly Medicare beneficiaries. Crit Care (2012) 1.07
Rates of decline in Alzheimer disease decrease with age. PLoS One (2012) 1.07
Nonsteroidal anti-inflammatory drugs are associated with increased neuritic plaques. Neurology (2010) 1.07
Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo. Neuroimage (2009) 1.05
Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer's disease cases. Dement Geriatr Cogn Disord (2010) 1.04
Sex differences in grey matter atrophy patterns among AD and aMCI patients: results from ADNI. Neuroimage (2011) 1.04
Executive dysfunction and presbycusis in older persons with and without memory loss and dementia. Cogn Behav Neurol (2010) 1.03
Neuropathology in the adult changes in thought study: a review. J Alzheimers Dis (2009) 1.02
Adult Changes in Thought study: dementia is an individually varying convergent syndrome with prevalent clinically silent diseases that may be modified by some commonly used therapeutics. Curr Alzheimer Res (2012) 1.01
Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology. J Neurochem (2013) 1.01
Alzheimer disease pathology in subjects without dementia in 2 studies of aging: the Nun Study and the Adult Changes in Thought Study. J Neuropathol Exp Neurol (2011) 0.99
Confirmation of the reported association of clonal chromosomal mosaicism with an increased risk of incident hematologic cancer. PLoS One (2013) 0.98
Oxidative stress and amyloid-beta pathology in normal individuals with a maternal history of Alzheimer's. Biol Psychiatry (2010) 0.98
Frailty and incident dementia. J Gerontol A Biol Sci Med Sci (2013) 0.98
The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harb Perspect Med (2012) 0.97
Life-course socioeconomic position and incidence of dementia and cognitive impairment without dementia in older Mexican Americans: results from the Sacramento area Latino study on aging. Am J Epidemiol (2011) 0.97
Olfactory copy number association with age at onset of Alzheimer disease. Neurology (2011) 0.95
Association between lifetime cigarette smoking and lewy body accumulation. Brain Pathol (2009) 0.95
Alzheimer's disease: a clinical practice-oriented review. Front Neurol (2012) 0.95
Elevated serum C-reactive protein relates to increased cerebral myoinositol levels in middle-aged adults. Cardiovasc Psychiatry Neurol (2012) 0.94
Neuropathologic correlates of cognition in a population-based sample. J Alzheimers Dis (2013) 0.94
Hormonal influences on cognition and risk for Alzheimer's disease. Curr Neurol Neurosci Rep (2010) 0.94
Enhancing the power of genetic association studies through the use of silver standard cases derived from electronic medical records. PLoS One (2013) 0.94
Apolipoprotein D takes center stage in the stress response of the aging and degenerative brain. Neurobiol Aging (2014) 0.93
Diagnosing dementia in the oldest-old. Maturitas (2011) 0.93
Gender and incidence of dementia in the Framingham Heart Study from mid-adult life. Alzheimers Dement (2014) 0.93
Type 2 diabetes mellitus and Alzheimer's disease. World J Diabetes (2014) 0.93
Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies. Clin Transl Imaging (2013) 0.91
Prospects for delaying the rising tide of worldwide, late-life dementias. Int Psychogeriatr (2010) 0.90
A randomized controlled clinical trial of the Seattle Protocol for Activity in older adults. J Am Geriatr Soc (2011) 0.90
Homeostatic disinhibition in the aging brain and Alzheimer's disease. J Alzheimers Dis (2011) 0.89
Clinicopathological outcomes of prospectively followed normal elderly brain bank volunteers. J Neuropathol Exp Neurol (2014) 0.89
Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause. J Steroid Biochem Mol Biol (2013) 0.89
Association between dental amalgam fillings and Alzheimer's disease: a population-based cross-sectional study in Taiwan. Alzheimers Res Ther (2015) 0.89
Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease. Mol Psychiatry (2015) 0.89
Effects of varying diagnostic criteria on prevalence of mild cognitive impairment in a community based sample. J Alzheimers Dis (2011) 0.87
Gene-based GWAS and biological pathway analysis of the resilience of executive functioning. Brain Imaging Behav (2014) 0.87
Prediction of Alzheimer dementia with short neuropsychological instruments. J Neural Transm (Vienna) (2009) 0.87
Is synaptic loss a unique hallmark of Alzheimer's disease? Biochem Pharmacol (2014) 0.87
Association of Traumatic Brain Injury With Late-Life Neurodegenerative Conditions and Neuropathologic Findings. JAMA Neurol (2016) 0.87
Cognitive decline and dementia in the oldest-old. Rambam Maimonides Med J (2012) 0.86
Anesthesia Exposure and Risk of Dementia and Alzheimer's Disease: A Prospective Study. J Am Geriatr Soc (2016) 0.86
Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease. J Biomed Biotechnol (2006) 0.86
Neuropathology-based risk scoring for dementia diagnosis in the elderly. J Alzheimers Dis (2009) 0.86
FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts? Q J Nucl Med Mol Imaging (2011) 0.86
The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double-blind, randomized, placebo-controlled trial. Eur J Nutr (2013) 0.85
Association of living alone and hospitalization among community-dwelling elders with and without dementia. J Gen Intern Med (2014) 0.85
Physical and mental health problems of the elderly in a rural community of sepang, selangor. Malays J Med Sci (2004) 0.84
Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66
Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet (2007) 14.05
Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature (2012) 13.71
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature (2009) 9.47
The eMERGE Network: a consortium of biorepositories linked to electronic medical records data for conducting genomic studies. BMC Med Genomics (2011) 9.20
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet (2013) 8.02
Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature (2009) 7.39
Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med (2006) 7.14
The Group Health medical home at year two: cost savings, higher patient satisfaction, and less burnout for providers. Health Aff (Millwood) (2010) 6.60
Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA (2008) 6.04
Patient-centered medical home demonstration: a prospective, quasi-experimental, before and after evaluation. Am J Manag Care (2009) 5.65
Survival after initial diagnosis of Alzheimer disease. Ann Intern Med (2004) 5.52
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis. Lancet Neurol (2008) 5.33
Synaptic, transcriptional and chromatin genes disrupted in autism. Nature (2014) 5.30
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol (2012) 5.18
Association between obesity and psychiatric disorders in the US adult population. Arch Gen Psychiatry (2006) 5.06
Glucose levels and risk of dementia. N Engl J Med (2013) 4.95
Systematic comparison of phenome-wide association study of electronic medical record data and genome-wide association study data. Nat Biotechnol (2013) 4.85
Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA (2003) 4.54
Assessing quality of life in older adults with cognitive impairment. Psychosom Med (2002) 4.52
Pathological correlates of dementia in a longitudinal, population-based sample of aging. Ann Neurol (2007) 4.47
The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med (2013) 4.37
Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging (2009) 4.36
Association between acute care and critical illness hospitalization and cognitive function in older adults. JAMA (2010) 4.36
Rising use of diagnostic medical imaging in a large integrated health system. Health Aff (Millwood) (2008) 4.05
Trends in the prevalence and mortality of cognitive impairment in the United States: is there evidence of a compression of cognitive morbidity? Alzheimers Dement (2008) 4.00
Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: using electronic medical records for genome- and phenome-wide studies. Am J Hum Genet (2011) 3.85
Association of the built environment with physical activity and obesity in older persons. Am J Public Health (2007) 3.60
Genomic research and wide data sharing: views of prospective participants. Genet Med (2010) 3.45
A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet (2010) 3.42
Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet (2009) 3.42
Glad you asked: participants' opinions of re-consent for dbGap data submission. J Empir Res Hum Res Ethics (2010) 3.29
Differential item functioning analysis with ordinal logistic regression techniques. DIFdetect and difwithpar. Med Care (2006) 3.03
The National Alzheimer's Coordinating Center (NACC) Database: an Alzheimer disease database. Alzheimer Dis Assoc Disord (2004) 2.97
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet (2011) 2.97
FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease. Brain (2007) 2.96
Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol (2005) 2.92
Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. Arch Neurol (2010) 2.91
Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry (2002) 2.86
Age and apolipoprotein E*4 allele effects on cerebrospinal fluid beta-amyloid 42 in adults with normal cognition. Arch Neurol (2006) 2.79
Association of incident dementia with hospitalizations. JAMA (2012) 2.74
Subjective memory deterioration and future dementia in people aged 65 and older. J Am Geriatr Soc (2004) 2.74
Phenotypic variability associated with progranulin haploinsufficiency in patients with the common 1477C-->T (Arg493X) mutation: an international initiative. Lancet Neurol (2007) 2.72
Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. JAMA (2013) 2.58
Performance-based physical function and future dementia in older people. Arch Intern Med (2006) 2.57
Earlier onset of Alzheimer disease symptoms in latino individuals compared with anglo individuals. Arch Neurol (2005) 2.54
Nonpharmacological therapies in Alzheimer's disease: a systematic review of efficacy. Dement Geriatr Cogn Disord (2010) 2.49
Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet (2012) 2.46
Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron (2013) 2.45
Age-varying association between statin use and incident Alzheimer's disease. J Am Geriatr Soc (2010) 2.34
Predictors of functional change: a longitudinal study of nondemented people aged 65 and older. J Am Geriatr Soc (2002) 2.30
The epidemiology of narcolepsy. Sleep (2007) 2.28
Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States. Alzheimers Dement (2011) 2.26
Racial inequities in the timing of breast cancer detection, diagnosis, and initiation of treatment. Med Care (2005) 2.25
Older adults' views of "successful aging"--how do they compare with researchers' definitions? J Am Geriatr Soc (2004) 2.24
Brain expression genome-wide association study (eGWAS) identifies human disease-associated variants. PLoS Genet (2012) 2.23
Defining the broader phenotype of autism: genetic, brain, and behavioral perspectives. Dev Psychopathol (2002) 2.21
GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology. Neurology (2012) 2.19
The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol (2010) 2.19
Identification of a novel gene on chromosome 7q11.2 interrupted by a translocation breakpoint in a pair of autistic twins. Genomics (2002) 2.16
GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease. Neuron (2013) 2.13
Regional variation in health care intensity and treatment practices for end-stage renal disease in older adults. JAMA (2010) 2.12
Dental X-rays and the risk of intracranial meningioma: a population-based case-control study. Cancer (2004) 2.11
Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. Am J Kidney Dis (2012) 2.10
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults. J Alzheimers Dis (2008) 2.08
High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum Mol Genet (2005) 2.08
Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions. Genet Med (2009) 2.07
Genome- and phenome-wide analyses of cardiac conduction identifies markers of arrhythmia risk. Circulation (2013) 2.06
Associations between physical performance and executive function in older adults with mild cognitive impairment: gait speed and the timed "up & go" test. Phys Ther (2011) 2.04
Temporal association of children's pesticide exposure and agricultural spraying: report of a longitudinal biological monitoring study. Environ Health Perspect (2002) 2.03
Paraoxonase activity, but not haplotype utilizing the linkage disequilibrium structure, predicts vascular disease. Arterioscler Thromb Vasc Biol (2003) 2.01
Genetic variants associated with the white blood cell count in 13,923 subjects in the eMERGE Network. Hum Genet (2011) 2.00
Implementing the learning health system: from concept to action. Ann Intern Med (2012) 1.99